ITP
Showing 1 - 25 of 444
Activity and Safety of Fostamatinib in Consecutive Adult ITP
Not yet recruiting
- ITP - Immune Thrombocytopenia
- +2 more
- (no location specified)
Jan 12, 2023
Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)
Not yet recruiting
- Primary Immune Thrombocytopenia (ITP)
- Ianalumab
- (no location specified)
Jun 5, 2023
Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP
Not yet recruiting
- Thrombopoietin Receptor Agonist
- (no location specified)
May 4, 2023
Immune Markers in Pediatric ITP
Not yet recruiting
- ITP - Immune Thrombocytopenia
- complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
- (no location specified)
Oct 17, 2023
Immune Thrombocytopenia Trial (peripheral blood and bone marrow withdrawal)
Not yet recruiting
- Immune Thrombocytopenia
- peripheral blood and bone marrow withdrawal
- (no location specified)
Jan 12, 2023
Course of COVID-19 in Prior, Ongoing or de Novo ITP. Evaluation
Recruiting
- Immune Thrombocytopenia
- +3 more
-
Brescia, Italy
- +7 more
Aug 24, 2022
ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)
Not yet recruiting
- ITP - Immune Thrombocytopenia
- hetrombopag 5mg po qd
- High-dose Dexamethasone
- (no location specified)
Jul 5, 2023
Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenic Purpura Trial (Romiplostim)
Completed
- Idiopathic Thrombocytopenic Purpura
- +2 more
- Romiplostim
- (no location specified)
Nov 10, 2022
Primary Immune Thrombocytopenia (ITP) Trial in Singapore (Ianalumab, Placebo, Corticosteroids)
Recruiting
- Primary Immune Thrombocytopenia (ITP)
- Ianalumab
- +2 more
-
Singapore, SingaporeNovartis Investigative Site
Jan 17, 2023
Primary Immune Thrombocytopenia (ITP) Trial in Tianjin (TPO-RAs, TPO-RAs combining anti-CD 20 mAb)
Not yet recruiting
- Primary Immune Thrombocytopenia (ITP)
- TPO-RAs
- TPO-RAs combining anti-CD 20 monoclonal antibody
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital, Chinese Aca
Feb 7, 2023
Some Cytokines Expression in ITP Primary Immune Thrombocytopenic
Recruiting
- Primary Immune Thrombocytopenia
- Plasma RNA isolation, qPCR analysis of micro RNA
- +2 more
-
Sohag, EgyptSohag University
May 7, 2022
Primary Immune Thrombocytopenia (ITP) Trial in Switzerland (Eltrombopag (Revolade®), standard therapy (without eltrombopag):
Recruiting
- Primary Immune Thrombocytopenia (ITP)
- Eltrombopag (Revolade®)
- standard therapy (without eltrombopag): HD-DXM
-
Aarau, Switzerland
- +5 more
Sep 5, 2022
Lupus Erythematosus, Systemic, Purpura, Thrombocytopenic, Idiopathic, Glucocorticoids Trial in Fuzhou (rapid GCs taper)
Enrolling by invitation
- Lupus Erythematosus, Systemic
- +3 more
- rapid GCs taper
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Aug 16, 2022
Immune Thrombocytopenia Trial in Jena
Recruiting
- Immune Thrombocytopenia
-
Jena, GermanyUniversity Hospital Jena
Mar 29, 2022
Anesthesia, Local Trial in Roskilde (Ropivacaine injection)
Recruiting
- Anesthesia, Local
- Ropivacaine injection
-
Roskilde, Zealand Region, DenmarkDepartment of Anaesthesiology and Intensive Care Medicine, Zeala
Feb 28, 2023
Immune Thrombocytopenia, Bruton Tyrosine Kinase Trial in Beijing (Zanubrutinib)
Recruiting
- Immune Thrombocytopenia
- Bruton Tyrosine Kinase
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Mar 6, 2022
Pediatric Primary Immune Thrombocytopenia (ITP)
Recruiting
- Primary Immune Thrombocytopenia
- data collection
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Oct 31, 2023
ITP Trial in Suzhou (autologous anti-BCMA chimeric antigen receptor T cells)
Recruiting
- ITP
- autologous anti-BCMA chimeric antigen receptor T cells
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Mar 31, 2022
Gut Microbiota in ITP
Recruiting
- ITP
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Jan 11, 2022
Multiple Sclerosis Trial in Los Angeles (Blood draw for future biomarker analysis)
Completed
- Multiple Sclerosis
- Blood draw for future biomarker analysis
-
Los Angeles, CaliforniaInvestigational Site Number 8400001
Mar 15, 2022
Immune Thrombocytopenia, Pregnancy Related Trial (intravenous immunoglobulin plus low dose recombinant human thrombopoietin
Not yet recruiting
- Immune Thrombocytopenia
- Pregnancy Related
- intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
- intravenous immunoglobulin
- (no location specified)
Dec 1, 2022
Evaluate Safety and Effectiveness of Hetrombopag in ITP or AA
Not yet recruiting
- Primary Immune Thrombocytopenia
- Aplastic Anemia
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Apr 11, 2022
Immune Thrombocytopenia (ITP) Trial (Neofordex®, Intravenous immunoglobulins)
Not yet recruiting
- Immune Thrombocytopenia (ITP)
- Neofordex®
- Intravenous immunoglobulins
- (no location specified)
Nov 22, 2021
Primary Immune Thrombocytopenia Trial (2.5mg/d Hetrombopag)
Not yet recruiting
- Primary Immune Thrombocytopenia
- 2.5mg/d Hetrombopag
- (no location specified)
Mar 28, 2022